Prognostic significance of myelodysplasia-related changes according to the WHO classification among ELN-intermediate-risk AML patients

Am J Hematol. 2015 Jan;90(1):E22-4. doi: 10.1002/ajh.23850. Epub 2014 Oct 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Disease-Free Survival
  • Europe
  • Humans
  • Karyotyping
  • Leukemia, Myeloid, Acute / classification*
  • Leukemia, Myeloid, Acute / genetics*
  • Leukemia, Myeloid, Acute / mortality
  • Leukemia, Myeloid, Acute / therapy
  • Middle Aged
  • Mutation
  • Myelodysplastic Syndromes / classification*
  • Myelodysplastic Syndromes / genetics*
  • Myelodysplastic Syndromes / mortality
  • Myelodysplastic Syndromes / therapy
  • Nuclear Proteins / genetics
  • Nucleophosmin
  • Prognosis
  • Remission Induction
  • Repressor Proteins / genetics
  • Risk
  • World Health Organization
  • Young Adult

Substances

  • ASXL1 protein, human
  • Nuclear Proteins
  • Repressor Proteins
  • Nucleophosmin